SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
主要作者: | Meem, Manila |
---|---|
其他作者: | Akter, Dr. Raushanara |
格式: | Thesis |
語言: | English |
出版: |
Brac University
2023
|
主題: | |
在線閱讀: | http://hdl.handle.net/10361/18081 |
相似書籍
-
A review on potential of PARP inhibitors in the treatment of prostate cancer
由: Islam, Saidul
出版: (2022) -
RIPK pathway, as a potential target, for cancer treatment - a review
由: Jahan, Nusrat
出版: (2024) -
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
由: Flora, Sanzida Alam
出版: (2024) -
Immunotherapy in the Management of Lung Cancer
由: Tasnim, Humayra
出版: (2022) -
A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
由: Ratu, Tabassum
出版: (2024)